An hiv-1 latency model for high throughput screening

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 5/10 (2006.01) C12N 7/01 (2006.01) C12N 15/867 (2006.01) C12Q 1/70 (2006.01)

Patent

CA 2632456

Isolated, latently infected T cell lines are provided that can be utilized in high throughput screening to discover compounds capable of activating HIV-I. The T cell lines harbor a latent HIV-I derived vector pro virus, which upon activation expresses a marker for late viral gene expression due to the insertion of the marker gene in the position of HIV-I envelope.

L'invention porte sur des lignées cellulaires T infectées de manière latente qui peuvent être utilisées dans le criblage à haut débit dans le but de découvrir des composés capables d'activer le VIH-I. Les lignées cellulaires T hébergent un vecteur dérivé du provirus VIH-1 latent, qui, lorsqu'il est activé, exprime un marqueur de l'expression génique virale tardive provoquée par l'introduction du gène marqueur dans la position de l'enveloppe du VIH-I.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

An hiv-1 latency model for high throughput screening does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with An hiv-1 latency model for high throughput screening, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and An hiv-1 latency model for high throughput screening will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1544233

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.